To describe gut microbiome and microbial metabolite changes associated with obesity in adolescents with type 1 diabetes (T1D), highlighting the significance of these changes for potential therapeutic interventions.
Key Findings:
Significant differences in bacterial community composition (β-diversity) by BMI group (P = .013), indicating distinct microbial profiles.
Higher ratio of Prevotella to Bacteroides in the obese group (P = .0058), which may influence metabolic pathways.
Increased relative abundance of Prevotella copri in the obese group, suggesting a potential microbial marker for obesity.
Functional profiling indicated upregulation of BCAA biosynthesis in the obese group, which could affect insulin sensitivity.
Higher stool SCFAs in the obese group compared to the lean group (P < .05 for all), indicating altered metabolic processes.
Interpretation:
The study identifies a distinct gut microbiome and metabolite signature associated with obesity in adolescents with T1D, suggesting potential targets for microbiome-based therapies and future research directions.
Limitations:
Small sample size limits generalizability and may affect the robustness of the findings.
Pilot study design may not provide definitive conclusions, necessitating larger studies for validation.
Conclusion:
Findings highlight the importance of gut microbiome alterations in understanding obesity in T1D, paving the way for future research and therapeutic strategies targeting the microbiome.
by Heba M Ismail, Dimuthu Perera, Rabindra Mandal, Linda A DiMeglio, Carmella Evans-Molina, Tamara Hannon, Joseph Petrosino, Sara Javornik Cregeen, Nathan W Schmidt
Metabolomics analysis identified higher uric acid levels in patients with lipedema and lymphedema, although associations weakened following adjustment for renal insufficiency.
